Selective suppression of cathepsin L results from elevations in lysosomal pH and is followed by proteolysis of tau protein

NeuroReport

Volumn 9, Issue 9, 1998, Pages 2089-2094

  Bednarski, Eric ^a   Lynch, Gary ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ageing; Alzheimer's disease; Lysosomal enzyme inhibitor; Neutralization

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; CHLOROQUINE; CHYMOSTATIN; ENZYME INHIBITOR; LYSOSOME ENZYME; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DEGENERATIVE DISEASE; HIPPOCAMPUS; LYSOSOME STORAGE DISEASE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

EID: 0032557892     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199806220-00033     Document Type: Article

References (25)

1. Hers HG. The Concept of Inborn Lysosomal Disease. Lysosomes and Storage Diseases. New York Academic Press, 1973: 147-171.
2. Love S, Bridges LR and Case CP. Brain 118, 119-129 (1995).
3. Purpura DP and Suzuki K. Brain Res 116, 1-21 (1976).
4. Hers HG and van Hoff F. Genetic abnormalities of lysosomes. In: Dingle JT and Fell HM. eds. Lysosomes in Biology and Pathology. Amsterdam: North-Holland 1969: 19-40.
5. Harman D. Lipofuscin and ceroid formation: The cellular recycling system. In: Porta ED, ed. Lipofuscin and Ceroid Pigments. New York: Plenum Press, 1990: 3-15.
6. Ivy GO, Kitani K and Ihara Y. Brain Res 498, 360-365 (1989).
7. Ivy GO, Shottler F, Wenzel J et al. Science 226, 985-987 (1984).
8. Nakanishi H, Tominaga K, Amano T et al. Exp Neurol 126, 119-128 (1994).
9. Nakamura Y, Takeda M, Suzuki H et al. Mech Age Dev 50, 215-225 (1989).
10. Bohley P and Seglen PO. Experimentia 48, 151-157 (1992).
11. Ivleva TS, Ogloblina TA, Litinskaya LL and Wiederschain Ya G. Biomed Sci 2, 398-402 (1991).
12. Bednarski E and Lynch G. J Neurochemistry 67, 1846-1855 (1996).
13. Bednarski E, Ribak CE and Lynch G. J Neurosci 17, 4006-4021 (1997).
14. Barrett AJ and Kirschke H. Methods Enzymol 80, 535-561 (1981).
15. Stoppini L, Buchs PA and Muller D. J Neurosci Methods 37, 173-182 (1991).
16. Buchs PA, Stoppini L and Muller D. Dev Brain Res 71, 81-91 (1993).
17. Inubushi T, Kakegawa H, Kishino Y and Katunuma N. J Biochem 116, 282-284 (1994).
18. Ohkuma S and Poole B. J Biol Chem 75, 3327-3331 (1978).
19. Kirschke H and Barrett AJ. Chemistry of Iysosomal proteases. In: Glaumann H and Ballard FJ, ed. Lysosomes: Their Role in Protein Breakdown. London: Academic Press, 1987: 193-238.
20. Richo GR and Conner GE. J Biol Chem 269, 14806-14812 (1994).
21. Dufour E, Dive V and Toma F. Biochim Biophys Acta 955, 58-64 (1988).
22. Machleidt W, Ritonja A, Popovic T et al. Human cathepsin B, H, and L. Characterization by amino acid sequences and some kinetics of inhibition by the kininogens. In: Turk V, ed. Cysteine Proteinases and their Inhibitors. Berlin: Walter de Gruyter, 1986: 3-18.
23. Brizzee KR, Cancilla PA, Sherwood N and Timiras PS. J Gerontol 2, 127-135 (1969).
24. Cataldo AM, Barnett JL, Berman SA et al. Neuron 14, 671-680 (1995).
25. Nieto A, Correas I, Montejo de Garcini E and Avila J. Biochem Biophys Res Commun 154, 660-667 (1988).